Skip to content

Author

Xin-Chang Xu

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

MIF-mediated intercellular crosstalk drives antigen-presenting-like cancer-associated fibroblast differentiation in triple-negative breast cancer via TGF-β signaling

Background Triple-negative breast cancer (TNBC) is characterized by an aggressive tumor microenvironment (TME) in which cancer-associated fibroblasts (CAFs) play a pivotal role. However, the molecular mechanisms governing the transformation of quiescent fibroblasts into distinct CAF subtypes within TNBC remain poorly u...

Jun Wang, Ye Li, Jia Zhu et al. · 0 citations
Open access Sep 2026

Comparative pharmacovigilance analysis of intravenous versus oral linezolid

This study aimed to compare the safety profiles of intravenous and oral linezolid by analyzing adverse event (AE) reports from the US Food and Drug Administration Adverse Event Reporting System. We extracted linezolid-related AE reports from US Food and Drug Administration Adverse Event Reporting System (2004 Q1–2025 Q...

Qi Zhou, Xin-Jun He, Xin-Chang Xu · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.